Vaxart, Inc. Class Action Lawsuit - VXRT

1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.

In order to be eligible to join the VXRT class action lawsuit, you must have incurred a loss on shares of Vaxart purchased during the class period listed above.

If you suffered a loss in Vaxart during the relevant time frame or pursuant to the relevant offering(s), you have until October 23, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.